OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From Therapy Resistance to Targeted Therapies in Prostate Cancer
Filipa Moreira‐Silva, Rui Henrique, Cármen Jerónimo
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12

Showing 12 citing articles:

Niosomes: Composition, Formulation Techniques, and Recent Progress as Delivery Systems in Cancer Therapy
Sergio Liga, Cristina Paul, Elena-Alina Moacă, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 223-223
Open Access | Times Cited: 32

Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer
Valeria Pecci, Fabiola Troisi, Aurora Aiello, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5

Insights on the Role of Polyphenols in Combating Cancer Drug Resistance
Mohd Farhan
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1709-1709
Open Access | Times Cited: 12

Innovative Approaches in the Synthesis and Optimization of Copper Complexes for Antitumor Therapies: A Comprehensive Review
Clara Maria Faria Silva, Ricardo Campos Lino, Mariana Cristina Teixeira de Moura, et al.
Molecules (2025) Vol. 30, Iss. 10, pp. 2104-2104
Open Access

Let’s Go 3D! New Generation of Models for Evaluating Drug Response and Resistance in Prostate Cancer
Tina Petrić, Maja Sabol
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5293-5293
Open Access | Times Cited: 6

Toad venom-derived bufadienolides and their therapeutic application in prostate cancers: Current status and future directions
Qingmei Ye, Xin Zhou, Fangxuan Han, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 6

Design, synthesis and biological evaluation of a new series of arylidene indanones as small molecules for targeted therapy of non-small cell lung carcinoma and prostate cancer
Mehlika Dilek Altıntop, Ahmet Özdemır, Halide Edip Temel, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114851-114851
Closed Access | Times Cited: 10

Strategies to Re-Sensitize Castration-Resistant Prostate Cancer to Antiandrogen Therapy
Belén Congregado Ruiz, I. Rivero Belenchón, Guillermo Cano, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1105-1105
Open Access | Times Cited: 5

MicroRNAs in Prostate Cancer: Implications for Treatment Response and Therapeutic Targets
Mohamed Ali Hussein, Gnanasekar Munirathinam
Cancers (2023) Vol. 15, Iss. 20, pp. 5023-5023
Open Access | Times Cited: 2

Novel Insights on the Role of Epigenetics in Androgen Receptor’s Expression in Prostate Cancer
Vânia Camilo, Mariana Brütt Pacheco, Filipa Moreira‐Silva, et al.
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1526-1526
Open Access | Times Cited: 1

Inhibition of proliferation, migration and invasion of RM-1 cells by Roemerine: Insights from In Vitro and In Vivo Studies
Jiajun Xu, Hongbin Ma
Tissue and Cell (2024) Vol. 93, pp. 102693-102693
Closed Access

Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer
Valeria Pecci, Fabiola Troisi, Aurora Aiello, et al.
Research Square (Research Square) (2023)
Open Access

Page 1

Scroll to top